Chiara Milanesi

Rozzano, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.

Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate.

Journal: Annals of hematology
Published: June 04, 2024

Iron trapping in macrophages reshapes the homeostasis of the haematopoietic system.

Iron trapping in macrophages reshapes the homeostasis of the haematopoietic system.

Journal: British journal of haematology
Published: May 28, 2024

CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.

CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.

Journal: Leukemia & lymphoma
Published: July 03, 2023

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.

Journal: Blood
Published: February 16, 2021

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Journal: Leukemia
Published: November 17, 2016

LNK mutations in familial myeloproliferative neoplasms.

LNK mutations in familial myeloproliferative neoplasms.

Journal: Blood
Published: May 25, 2016

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia.

Journal: Haematologica
Published: August 08, 2015

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

Journal: Blood
Published: July 31, 2015

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms.

Journal: Leukemia
Published: July 14, 2015

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene.

Journal: Annals of hematology
Published: March 26, 2015

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.

Journal: Blood
Published: July 03, 2014

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.

Journal: Blood
Published: February 21, 2014
Showing 1-12 of 16

Last Updated: 09/26/2026